Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Your are on :  Markets   |  News Analysis    |  Corporate Results   |Detailed News   
Back
Glenmark Life Sciences standalone net profit rises 1.23% in the December 2022 quarter
27-Jan-23   14:17 Hrs IST

Net profit of Glenmark Life Sciences rose 1.23% to Rs 104.99 crore in the quarter ended December 2022 as against Rs 103.71 crore during the previous quarter ended December 2021. Sales rose 3.49% to Rs 540.73 crore in the quarter ended December 2022 as against Rs 522.50 crore during the previous quarter ended December 2021.

ParticularsQuarter Ended
 Dec. 2022Dec. 2021% Var.
Sales540.73522.50 3
OPM %26.9027.96 -
PBDT151.90149.54 2
PBT141.14139.80 1
NP104.99103.71 1

Powered by Capital Market - Live News

Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)